The U.K.’s health minister on Wednesday rushed to defend AstraZeneca’s decision to pause a closely-watched coronavirus vaccine trial due to safety concerns, saying that the decision is not necessarily a setback to its development. AstraZeneca announced that the pause was due to a potentially unexplained illness in one of its trials. The pharma giant’s shares […] Read more